X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
midgut (384) 384
index medicus (293) 293
animals (238) 238
humans (149) 149
female (128) 128
entomology (104) 104
male (103) 103
biochemistry & molecular biology (80) 80
middle aged (73) 73
analysis (72) 72
survival (72) 72
neuroendocrine tumors (70) 70
physiology (69) 69
tumors (67) 67
oncology (64) 64
insects (63) 63
aged (62) 62
surgery (58) 58
adult (57) 57
neuroendocrine tumors - pathology (56) 56
proteins (55) 55
fungi (51) 51
management (49) 49
mosquitoes (47) 47
zoology (47) 47
gene expression (46) 46
larvae (46) 46
life sciences (46) 46
liver metastases (45) 45
prognosis (44) 44
research (43) 43
cell biology (42) 42
medicine (42) 42
metastasis (42) 42
multidisciplinary sciences (42) 42
malaria (40) 40
retrospective studies (40) 40
biology (39) 39
hindgut (39) 39
midgut carcinoid-tumors (39) 39
physiological aspects (39) 39
cancer (38) 38
enzymes (38) 38
research article (37) 37
parasitology (36) 36
endocrinology & metabolism (35) 35
parasitic diseases (35) 35
aged, 80 and over (34) 34
expression (34) 34
medicine & public health (33) 33
microbiology (33) 33
article (32) 32
health aspects (32) 32
metastases (32) 32
neuroendocrine tumors - mortality (32) 32
endocrine tumors (31) 31
foregut (31) 31
aquatic insects (29) 29
epidemiology (29) 29
molecular sequence data (29) 29
neoplasms (29) 29
neuroendocrine tumors - surgery (29) 29
prognostic-factors (29) 29
carcinoid-tumors (28) 28
enets consensus guidelines (28) 28
liver neoplasms - secondary (28) 28
manduca-sexta (28) 28
parasites (28) 28
science (28) 28
aedes-aegypti (27) 27
neuroendocrine tumors - therapy (27) 27
amino acid sequence (26) 26
infections (26) 26
intestinal neoplasms - pathology (26) 26
medical and health sciences (26) 26
medicin och hälsovetenskap (26) 26
neuroendocrine tumor (26) 26
toxicity (26) 26
identification (25) 25
metabolism (25) 25
pancreas (25) 25
anopheles (24) 24
classification (24) 24
genes (24) 24
insecticides (24) 24
mosquito (24) 24
survival rate (24) 24
cells (23) 23
disease transmission (23) 23
gastroenterology & hepatology (23) 23
neuroendocrine tumors - diagnosis (23) 23
pancreatic neoplasms - pathology (23) 23
patients (23) 23
somatostatin (23) 23
vector-borne diseases (23) 23
ecology (22) 22
larva - metabolism (22) 22
liver (22) 22
malpighian tubules (22) 22
neoplasm staging (22) 22
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer and Metastasis Reviews, ISSN 0167-7659, 3/2014, Volume 33, Issue 1, pp. 353 - 359
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 04/2018, Volume 59, Issue 4, p. 9N
On January 26, the U.S. Food and Drug Administration (FDA) announced approval for a new drug application for Lutathera for treatment of somatostatin... 
Drugs | Regulatory agencies | Effectiveness | Incentives | Hindgut | Midgut | Medical treatment | Radioisotopes | Radiation therapy | Drug development | Nets | Gastrointestinal diseases | Somatostatin | Foregut | Tumors | Neuroendocrine tumors
Journal Article
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 10/2019, Volume 46, Issue 11, pp. 2252 - 2259
Journal Article
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 7/2015, Volume 42, Issue 8, pp. 1238 - 1246
Increasing evidence supports the value of peptide receptor radionuclide therapy (PRRT) in patients with metastatic neuroendocrine tumours (NET), but there are... 
PRRT | Midgut NET | Small intestinal NET | Somatostatin Receptor targeted radionuclide therapy | Oncology | Radiopeptide therapy | Medicine & Public Health | Orthopedics | Nuclear Medicine | Imaging / Radiology | Cardiology | NET | Small bowel NET | Functional NET | Neuroendocrine tumors
Journal Article
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 07/2015, Volume 42, Issue 8, pp. 1238 - 1246
Journal Article
Nuclear Medicine Communications, ISSN 0143-3636, 07/2017, Volume 38, Issue 7, pp. 593 - 600
OBJECTIVELutetium-177 DOTA-D-Phe1-Tyr3-octreotide (Lu-DOTATATE) is a treatment option for patients with well-differentiated metastatic neuroendocrine tumours.... 
SURVIVAL | MANAGEMENT | RESPONSE EVALUATION | NEOPLASMS | peptide receptor radionuclide therapy | PANCREATIC NEUROENDOCRINE TUMORS | oncology | RADIOLABELED SOMATOSTATIN ANALOG | lutetium-177-DOTATATE | MIDGUT | RECEPTOR RADIONUCLIDE THERAPY | LU-177-DOTATATE | neuroendocrine tumours | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Index Medicus
Journal Article
ZENTRALBLATT FUR CHIRURGIE, ISSN 0044-409X, 06/2014, Volume 139, Issue 3, pp. 276 - 283
Background: Neuroendocrine tumours (NET) are rare and heterogeneous neoplasia. To obtain valid data on epidemiology, diagnostics, therapy, prognosis and risk... 
MANAGEMENT | PROGNOSTIC-FACTORS | LONG-TERM SURVIVAL | CLASSIFICATION | CONSENSUS GUIDELINES | NEURO ENDOCRINE TUMORS | German neuroendocrine tumour registry | CARCINOID-TUMORS | DISEASE | MIDGUT | survival rate | proliferation-based grading | WHO classification | EPIDEMIOLOGY | surgery
Journal Article
Fisheries Science, ISSN 0919-9268, 11/2019, Volume 85, Issue 6, pp. 1027 - 1036
Journal Article
Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, ISSN 1098-3015, 05/2017, Volume 20, Issue 5, p. A138
OBJECTIVES: To describe the frequency and nature of SSA dose escalations among patients with advanced GEP-NET treated at a tertiary referral center. METHODS:... 
Women | Midgut | Oncology | Octreotide | Metastasis | Dosage | Medical diagnosis | Patients | Metastases | Cohort analysis | Databases | Pancreatic cancer | Pharmacy | Somatostatin | Pancreas | Release | Tumors | Neuroendocrine tumors | Cancer
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 05/2017, Volume 58, p. 244
Objectives: Neuroendocrine tumor progression is associated with decline in quality of life, both due to tumor and hormone-related symptoms. The Phase III... 
Nuclear medicine | Statistical analysis | Midgut | Diarrhea | Octreotide | Hormones | Patients | Quality of life | Nets | Lutetium isotopes | Public health | Tumors | Neuroendocrine tumors
Journal Article
Journal Article
Investigational New Drugs, ISSN 0167-6997, 06/2019, Volume 37, Issue 3, pp. 573 - 578
Neuroendocrine tumors (NET) are rare tumors for which somatostatin analogs (SSA) are used not only for symptom control due to a functioning tumor, but also for... 
Octoreotide | Foregut NET | Neuroendocrine tumor | Hindgut NET | Lanreotide | Somatostatin analog | Complications and side effects | Dosage and administration | Effectiveness | Hindgut | Midgut | Liver | Medical treatment | Medical services | Disease control | Survival | Patients | Subgroups | Metastases | Analogs | Studies | Somatostatin | Foregut | Tumors | Neuroendocrine tumors
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 08/2018, Volume 59, Issue 8, p. 19N
SNMMI, the Mayo Clinic (Rochester MN), Washington University School of Medicine in St. Louis, and Memorial Sloan Kettering Cancer Center (New York NY) on May... 
Therapy | Regulatory agencies | Hindgut | Midgut | Amino acids | FDA approval | Associations | Cancer therapies | Nets | Lutetium isotopes | Adults | Somatostatin | Statins | Foregut | Cancer | Neuroendocrine tumors
Journal Article
JOURNAL OF GASTROINTESTINAL ONCOLOGY, ISSN 2078-6891, 10/2019, Volume 10, Issue 5, pp. 928 - 934
Background: Midgut neuroendocrine tumor (NET) patients are often diagnosed at advanced stages with extensive mesenteric nodal and hepatic metastasis. The only... 
MESENTERIC METASTASES | Midgut neuroendocrine tumors (midgut NETs) | ONCOLOGY | cytoreduction | debulking surgery | GASTROENTEROLOGY & HEPATOLOGY | intraoperative chemotherapy | Original
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.